Abbott Laboratories (XSWX:ABT) GF Score: 80/100 (As of Jun. 28, 2026) — Near Median


XSWX:ABT Abbott Laboratories XSWX:ABT
80 GF Score
Price CHF76.00
GF Value CHF104.56
View Full Analysis

What is Abbott Laboratories GF Score?

Abbott Laboratories XSWX:ABT +0.66% 80 GF Score is 80 as of Jun. 28, 2026, which is 6% below its 10-year median of 85.00. GuruFocus rates XSWX:ABT with a GF Score™ of 80/100 and a GF Value™ of CHF104.56.

Abbott Laboratories has the GF Score of 80, which implies that the company is Likely to have average performance.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 6/10
2. Profitability Rank : 8/10
3. Growth Rank : 8/10
4. GF Value Rank : 8/10
5. Momentum Rank : 2/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Abbott Laboratories is Likely to have average performance.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Abbott Laboratories  (XSWX:ABT) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Abbott Laboratories GF Score Related Terms

XSWX:ABT vs SYK, MDT, BSX: GF Score Comparison

For the Medical Devices subindustry, Abbott Laboratories's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott Laboratories GF Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's GF Score distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's GF Score falls into.


XSWX:ABT
80GF Score
Abbott Laboratories XSWX:ABT
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 80 mean?
Abbott Laboratories (XSWX:ABT) has a GF Score of 80 as of Jun. 28, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Abbott Laboratories and its competitors. This is near median its historical median of 85.00. Over the past decade, Abbott Laboratories' GF Score has ranged from 20.00 to 97.00.
Is Abbott Laboratories' GF Score too high?
Abbott Laboratories' current GF Score of 80 is near median its 10-year median of 85.00. Over the past 10 years, this metric has ranged from a low of 20.00 to a high of 97.00. Overall, Abbott Laboratories has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' GF Score compare to SYK and MDT?
Abbott Laboratories' GF Score of 80 can be compared against companies in the Medical Devices & Instruments industry. Historically, Abbott Laboratories' own GF Score has ranged from 20.00 to 97.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Devices & Instruments company?
A good GF Score depends on the Medical Devices & Instruments industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current GF Score is 80, which is near median its own 10-year median of 85.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current GF Score of 80. The stock's GF Value™ is CHF104.56, compared to a current price of CHF76.00 — trading 27.3% below its estimated fair value. The current GF Score is 80, which is near median its 10-year median of 85.00. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current GF Score is 80 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF76.00 is trading 27.3% below its estimated GF Value™ of CHF104.56.

Key valuation signals for XSWX:ABT:

  • GF Score: 80 (near median its 10-year median of 85.00)
  • GF Value™: CHF104.56 vs. price of CHF76.00 (27.3% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for XSWX:ABT

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF76.00
Price
CHF104.56
GF Value